Dr. Robert Redfield, Director of the Centers for Disease Control and Prevention speaks while U.S. President Donald Trump listens during the daily briefing of the coronavirus task force at the White House on April 22, 2020 in Washington, DC. Drew Angerer | Getty Images Public health specialists and the medical community are criticizing the Trump… Read More »
Dive Brief: CMS on Tuesday released guidelines for health facilities to resume nonemergency services in states ready to begin the second phase of reopening under the Trump administration’s general guidance. The document promotes continued use of telemedicine as much as possible and states facilities must maintain the necessary space, equipment and workforce in case of… Read More »
Print this page PRINCETON, N.J.–(BUSINESS WIRE)–May 15, 2020 — Bristol Myers Squibb (NYSE: BMY) today announced that Pomalyst ® (pomalidomide) was approved by the U.S. Food and Drug Administration (FDA) for patients with AIDS-related Kaposi sarcoma whose disease has become resistant to highly active antiretroviral therapy (HAART), or in patients with Kaposi sarcoma who are… Read More »